FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138585071> ?p ?o ?g. }

• W2138585071 endingPage "E93" @default.
• W2138585071 startingPage "E86" @default.
• W2138585071 abstract "<h3>Background</h3> The decision to use universal primary antimould prophylaxis to prevent invasive aspergillosis in patients with acute leukemia depends on the incidence of infection at individual centres. We determined our institution’s incidence of invasive aspergillosis among patients who received remission–induction chemotherapy for acute leukemia to evaluate the potential benefits of primary antimould prophylaxis. <h3>Methods</h3> We conducted this retrospective cohort study at a Canadian tertiary care centre. From the central pharmacy registries, we retrieved records for all adult patients for whom remission–induction chemotherapy for acute leukemia was prescribed between 2008 and 2010. We retrieved clinical, microbiologic, pathologic and radiologic data from the patients’ medical charts. The primary outcome was a diagnosis of probable or proven invasive aspergillosis up to 180 days after resolution of aplasia. <h3>Results</h3> We retrieved records for 123 patients with acute leukemia. Twenty-two of these patients did not receive the prescribed chemotherapy and were excluded from the analysis. Of the 101 patients included, 77 (76.2%) had acute myeloid leukemia. Overall, 136 courses of chemotherapy were administered, with more than 1 course administered to 26 (25.7%) of the 101 patients. In 9 of the patients (8.9%; 95% confidence interval 4.2%–16.2%), invasive aspergillosis was diagnosed (3 proven and 6 probable cases) a median of 19 (range 11–34) days after initiation of chemotherapy. In 7 (78%) of these 9 patients, invasive aspergillosis occurred during the first course of chemotherapy. Three patients died within the first year after diagnosis of invasive aspergillosis. <h3>Interpretation</h3> We found a high incidence (8.9%) of invasive aspergillosis at our centre. This finding triggered the introduction of targeted antimould prophylaxis for patients with acute leukemia who were undergoing remission–induction chemotherapy." @default.
• W2138585071 created "2016-06-24" @default.
• W2138585071 creator A5002514817 @default.
• W2138585071 creator A5018106790 @default.
• W2138585071 creator A5031075208 @default.
• W2138585071 creator A5038274485 @default.
• W2138585071 creator A5066593692 @default.
• W2138585071 creator A5080425175 @default.
• W2138585071 creator A5082794321 @default.
• W2138585071 date "2014-05-07" @default.
• W2138585071 modified "2023-10-01" @default.
• W2138585071 title "Incidence of invasive aspergillosis following remission-induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centre" @default.
• W2138585071 cites W1516462031 @default.
• W2138585071 cites W1531476564 @default.
• W2138585071 cites W1613051972 @default.
• W2138585071 cites W1750025028 @default.
• W2138585071 cites W1849607011 @default.
• W2138585071 cites W1964477069 @default.
• W2138585071 cites W1967828500 @default.
• W2138585071 cites W1975997437 @default.
• W2138585071 cites W1977267736 @default.
• W2138585071 cites W1980167770 @default.
• W2138585071 cites W1983926295 @default.
• W2138585071 cites W1988896736 @default.
• W2138585071 cites W1989267818 @default.
• W2138585071 cites W1989345554 @default.
• W2138585071 cites W2001579789 @default.
• W2138585071 cites W2007500712 @default.
• W2138585071 cites W2015803217 @default.
• W2138585071 cites W2018954579 @default.
• W2138585071 cites W2035663399 @default.
• W2138585071 cites W2091172892 @default.
• W2138585071 cites W2094481702 @default.
• W2138585071 cites W2096609116 @default.
• W2138585071 cites W2101461845 @default.
• W2138585071 cites W2101879721 @default.
• W2138585071 cites W2107040094 @default.
• W2138585071 cites W2109374935 @default.
• W2138585071 cites W2118095577 @default.
• W2138585071 cites W2123134253 @default.
• W2138585071 cites W2123708935 @default.
• W2138585071 cites W2127402627 @default.
• W2138585071 cites W2133195608 @default.
• W2138585071 cites W2133328722 @default.
• W2138585071 cites W2134441638 @default.
• W2138585071 cites W2137797161 @default.
• W2138585071 cites W2138992100 @default.
• W2138585071 cites W2139621961 @default.
• W2138585071 cites W2139678747 @default.
• W2138585071 cites W2141698097 @default.
• W2138585071 cites W2146648542 @default.
• W2138585071 cites W2148565002 @default.
• W2138585071 cites W2151082945 @default.
• W2138585071 cites W2151483063 @default.
• W2138585071 cites W2161724792 @default.
• W2138585071 cites W2163736196 @default.
• W2138585071 cites W2164085479 @default.
• W2138585071 cites W2166734004 @default.
• W2138585071 cites W2271925942 @default.
• W2138585071 cites W2340005443 @default.
• W2138585071 cites W2606778298 @default.
• W2138585071 doi "https://doi.org/10.9778/cmajo.20130062" @default.
• W2138585071 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4114061" @default.
• W2138585071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25077134" @default.
• W2138585071 hasPublicationYear "2014" @default.
• W2138585071 type Work @default.
• W2138585071 sameAs 2138585071 @default.
• W2138585071 citedByCount "7" @default.
• W2138585071 countsByYear W21385850712016 @default.
• W2138585071 countsByYear W21385850712017 @default.
• W2138585071 countsByYear W21385850712018 @default.
• W2138585071 countsByYear W21385850712022 @default.
• W2138585071 countsByYear W21385850712023 @default.
• W2138585071 crossrefType "journal-article" @default.
• W2138585071 hasAuthorship W2138585071A5002514817 @default.
• W2138585071 hasAuthorship W2138585071A5018106790 @default.
• W2138585071 hasAuthorship W2138585071A5031075208 @default.
• W2138585071 hasAuthorship W2138585071A5038274485 @default.
• W2138585071 hasAuthorship W2138585071A5066593692 @default.
• W2138585071 hasAuthorship W2138585071A5080425175 @default.
• W2138585071 hasAuthorship W2138585071A5082794321 @default.
• W2138585071 hasBestOaLocation W21385850711 @default.
• W2138585071 hasConcept C120665830 @default.
• W2138585071 hasConcept C121332964 @default.
• W2138585071 hasConcept C126322002 @default.
• W2138585071 hasConcept C141071460 @default.
• W2138585071 hasConcept C167135981 @default.
• W2138585071 hasConcept C195910791 @default.
• W2138585071 hasConcept C203014093 @default.
• W2138585071 hasConcept C2776391196 @default.
• W2138585071 hasConcept C2776611710 @default.
• W2138585071 hasConcept C2776694085 @default.
• W2138585071 hasConcept C2776863199 @default.
• W2138585071 hasConcept C2778461978 @default.
• W2138585071 hasConcept C61511704 @default.
• W2138585071 hasConcept C71924100 @default.
• W2138585071 hasConcept C72563966 @default.
• W2138585071 hasConceptScore W2138585071C120665830 @default.

• next